Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

NCT ID: NCT01645345

Last Updated: 2020-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the safety and efficacy of the Pixel RF (fractional radio frequency) module in the treatment of acne scars and wrinkles.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design will be a prospective open label study. Up to 20 subjects of both genders with acne scars and/or wrinkles in the face will be recruited. The subjects will be treated once on clean acne scarred skin and three times on the the wrinkled skin with the Pixel RF handpiece. Each treatment duration will be approximately 30 minutes. The initial power and number of passes parameters shall be set according to the clinical indication and skin type of the subject treated (as well as the results of test sites).

Clinical improvement will be assessed by the investigator physician from the visual appearance of the treated area according to the following scale: -1 for exacerbation, 0 no change, 1 for 1%-25% improvement, 2 for 25%-50% improvement, 3 for 50%-75% improvement, and 4 for 75%-99% improvement. Adverse side effects will be scored by clinical evaluation of erythema, edema, and burns. Real-time assessments will be made as well by the investigators. Treatment and results will be documented in a Case Report Form and follow-up sessions (1, 5 days after the treatment and 1 month and 3 months after the treatment).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wrinkles Acne Scars

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RF Pixel handpiece treatment

There is only one arm, and that is a treatment arm. For patients with wrinkles and acne scars, they are being treated with the RF Pixel handpiece to decrease the appearance of these cosmetic deficiencies. The improvement is documented in before and after photographs.

Group Type OTHER

Alma Lasers Accent RF Pixel handpiece

Intervention Type DEVICE

Treatment with fractionated RF Pixel device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Alma Lasers Accent RF Pixel handpiece

Treatment with fractionated RF Pixel device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subject 18-60 years of age.
* Clinically documented rolling and boxcar acne scars and/or wrinkles score of 2 or 3 per the Rao-Goldman scale (see section 6.5.1 for wrinkle classification).
* Limitation to acne scared and wrinkles area: face.
* Patients must commit to all follow-up visits.

Exclusion Criteria

Subjects meeting any of the following criteria will be excluded from participation:

* Bacterial or viral infection
* Impaired immune system
* Isotretinoin (Accutane, Amnesteem, Claravis, and Sotret) in the past 6 months
* Scleroderma
* Extensive radiation therapy
* Burns in the treatment area
* Poor healing in the treatment area
* Metal implants near the treatment area
* Implantable pacemaker or automatic defibrillator/cardioverter (AICD)
* Ablative/non-ablative cosmetic intervention (deep peeling) in the past 3 months in the areas to be treated
* Active cancer
* Active collagen or vascular disease
* Pregnancy or IVF procedure
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alma Lasers Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Metropolitan MD

Glenview, Illinois, United States

Site Status

Dr. Zimmerman

Las Vegas, Nevada, United States

Site Status

Victoria Cirillo-Hyland

Bryn Mawr, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

022012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.